Ikena Oncology Inc.

NASDAQ: IKNA · Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM

Ikena Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a 659K 1.84M 3.85M 9.16M 13.95M 19.17M 17.55M 15.62M 30.39M 27.73M 30.9M 30.99M 10.83M 9.92M 9.44M
Cost of Revenue
n/a 92K 311K 616K 858K 1.35M 1.13M 1.21M 19.82M 34.72M 49.06M 61.02M 55.54M 51.43M 47.11M 58.17M 52.02M 46.98M
Gross Profit
n/a -92K -311K 43K 986K 2.5M 8.03M 12.74M -648K -17.17M -33.44M -30.63M -27.82M -20.53M -16.12M -47.34M -42.1M -37.53M
Operating Income
-44.47M -50.86M -55.71M -65.1M -72.19M -75.55M -75.42M -68.62M -67M -69.46M -70.9M -53M -49.64M -41.38M -34.14M -62.98M -54.69M -47.06M
Interest Income
n/a n/a n/a 2.27M 4.43M 5.81M 6.54M 5.17M 3.58M 2.71M 2.15M 1.25M 686K 185K 17K 17K 10K 4K
Pretax Income
-30.64M -41.55M -49.08M -59.66M -66.78M -70.23M -68.33M -62.77M -62.77M -66.14M -68.77M -51.87M -49.05M -41.24M -34.12M -62.96M -54.67M -47.03M
Net Income
-30.74M -41.71M -49.23M -59.6M -66.71M -70.09M -68.17M -61.76M -61.21M -64.13M -66.63M -50.75M -48.47M -41.12M -34.12M -62.96M -54.67M -47.03M
Selling & General & Admin
22.43M 23.32M 23.68M 24.38M 25.63M 25.65M 24.93M 21.56M 20.95M 21.47M 22.2M 22.36M 21.83M 20.84M 18.02M 15.64M 12.6M 9.53M
Research & Development
19.14M 24.85M 30.56M 39.95M 34.32M 39.75M 45.88M 47.55M 65.21M 65.53M 64.32M 61.02M 55.54M 51.43M 47.11M 58.17M 52.02M 46.98M
Other Expenses
2.9M 2.59M 1.15M 791K 13.45M 13.44M 13.45M 13.59M 80K 39K -10K -129K -84K -31K 22K 19K 23K 38K
Operating Expenses
44.47M 50.77M 55.4M 65.14M 73.42M 78.87M 84.27M 82.57M 86.16M 87M 86.52M 83.38M 77.37M 72.28M 65.12M 73.82M 64.61M 56.51M
Interest Expense
n/a n/a n/a 1.3M 1.3M 1.3M 1.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
35.72M 50.86M 55.71M 65.76M 74.04M 79.39M 84.58M 82.57M 86.16M 87M 86.52M 83.38M 77.37M 72.28M 65.12M 73.82M 64.61M 56.51M
Income Tax Expense
20K 97K 152K -63K -73K -135K -162K -1.02M -1.55M -2.02M -2.14M -1.12M -583K -123K n/a n/a n/a n/a
Shares Outstanding (Basic)
48.26M 48.26M 48.26M 48.26M 48.26M 48.26M 47.81M 43.44M 39.29M 36.26M 36.26M 36.26M 36.16M 36.08M 35.86M 35.86M 35.85M 3.85M
Shares Outstanding (Diluted)
48.26M 48.26M 48.26M 48.26M 48.26M 48.26M 47.81M 43.44M 39.29M 36.26M 36.26M 36.26M 36.16M 36.08M 35.86M 35.86M 35.85M 3.85M
EPS (Basic)
-0.66 -0.88 -1.03 -1.23 -1.42 -1.58 -1.64 -1.59 -1.65 -1.76 -1.83 -1.39 -1.33 -1.13 -3.19 -5.13 -5.17 -5.18
EPS (Diluted)
-0.66 -0.88 -1.03 -1.23 -1.42 -1.58 -1.64 -1.59 -1.65 -1.76 -1.83 -1.39 -1.33 -1.13 -3.19 -5.13 -5.17 -5.18
EBITDA
-41.61M -47.91M -54.06M -63.58M -71.34M -74.54M -74.4M -67.7M -66.1M -68.65M -70.15M -52.29M -49.01M -40.74M -33.59M -62.53M -54.38M -46.36M
EBIT
-33.13M -48.27M -54.55M -64.29M -72.19M -75.55M -75.42M -68.62M -67M -69.46M -70.9M -52.99M -49.64M -41.37M -34.13M -62.98M -54.69M -47.06M
Depreciation & Amortization
266K 358K 490K 706K 858K 1.35M 1.36M 1.44M 1.72M 1.75M 2.01M 2.1M 1.98M 1.8M 1.67M 1.28M 485K 588K